Rakuten Medical teams on light-based cancer treatment with Taiwan company

California startup recruits partner OEP for photoimmunotherapy in Asian markets

20250625N Rakuten Medical photoimmunotherapy

Photoimmunotherapy involves activating drugs with light to destroy cancer cells. (Rakuten Medical)

HIDEAKI RYUGEN

TAIPEI -- Cancer treatment company Rakuten Medical said Wednesday that it will collaborate with Taiwanese drugmaker Orient Europharma (OEP) to expand the reach of an immunotherapy method in Asia.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.